Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthy donor leukapheresis for T-cell and tolerogenic dendritic cell manufacturing validation
NL-OMON52474Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in hematological and immunological diseases, sponsored by Leiden University Medical Center. Primary endpoint: Successful mononuclear cell collection. Started Jan 2023; status: recruiting.
02
Conditions
hematological and immunological diseases
Beyond the preview
Go deeper on NL-OMON52474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52474.